acivicin and Bone Loss, Osteoclastic

acivicin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hibi, T; Ikeda, K; Ikeda, Y; Ishizuka, Y; Kawahara, M; Kondo, T; Niida, S; Suzuki, Y; Taniguchi, N1

Other Studies

1 other study(ies) available for acivicin and Bone Loss, Osteoclastic

ArticleYear
Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.
    The Journal of biological chemistry, 2004, Feb-13, Volume: 279, Issue:7

    Topics: Animals; Bone Marrow Cells; Bone Resorption; Calcitonin; Carrier Proteins; Cell Line, Tumor; Cells, Cultured; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Glutathione; Immunoblotting; Isoxazoles; Ligands; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Molecular Sequence Data; Oocytes; Osteoclasts; Protein Binding; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Xenopus

2004